Interleukin 8 Receptor Beta / IL8RB (CXCR2) Antibody (PE)

Este producto es parte de CXCR - C-X-C motif chemokine receptor
Product Graph
637€ (100 tests)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Interleukin 8 Receptor Beta / IL8RB (CXCR2) Antibody (PE)
category
Primary Antibodies
provider
Abbexa
reference
abx270934
tested applications
FCM

Description

Interleukin 8 Receptor Beta (IL8Rb) Antibody (PE) is a Rabbit Polyclonal Antibody conjugated to PE against Interleukin 8 Receptor Beta (IL8Rb) for use in flow cytometry.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetInterleukin 8 Receptor Beta / IL8RB (CXCR2)
HostRabbit
ReactivityHuman
Recommended DilutionFCM: 1-5 µl/106 cells. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationPE
IsotypeIgG
PurificationPurified by antigen-specific affinity chromatography.
Size 1100 tests
Size 2200 tests
Size 3500 tests
FormLiquid
Tested ApplicationsFCM
Buffer0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
AvailabilityPlease enquire.
StorageAliquot and store at 2°C to 8°C upon receipt. Avoid exposure to light.
Dry IceNo
AliasCXCR2,C-X-C motif chemokine receptor 2,CD182,IL8R2,IL8RA,IL8RB,CMKAR2,WHIMS2,CDw128b,KC receptor,CXC-R2,high affinity interleukin-8 receptor B,CD128,Gpcr16
BackgroundAntibody anti-CXCR2
StatusRUO

Descripción

CXCR2 is a G protein-coupled receptor that binds IL-8 and other CXC chemokines like Groα, Groβ, and NAP-2. It is mainly expressed on neutrophils, endothelial cells, and monocytes, mediating chemotaxis, neutrophil activation, and cytokine release during inflammation. CXCR2 signaling activates pathways such as PI3K, MAPK, and NF-κB, while its rapid desensitization and internalization regulate signal duration. CXCR2 is critical for immune surveillance and inflammation but also contributes to diseases like COPD, asthma, and rheumatoid arthritis due to excessive neutrophil infiltration. In cancer, CXCR2 promotes tumor progression, angiogenesis, and metastasis by recruiting myeloid-derived suppressor cells (MDSCs) and endothelial cells to the tumor microenvironment, enhancing immunosuppression and vascularization. CXCR2 inhibition reduces tumor growth and inflammation, highlighting its therapeutic potential. It also regulates leukocyte trafficking and tissue repair but contributes to pathologies like cystic fibrosis and inflammatory bowel disease (IBD) when dysregulated. Overall, CXCR2 is key for immune cell recruitment and inflammation, balancing host defense with disease progression.

Related Products

EH4313

Human CXCR2(C-X-C chemokine receptor type 2) ELISA Kit

Ver Producto
EM1613

Mouse CXCR2(C-X-C chemokine receptor type 2) ELISA Kit

Ver Producto
ER1623

Rat CXCR2(C-X-C chemokine receptor type 2) ELISA Kit

Ver Producto